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 Transient intracellular elevations of Ca2+ are common signaling mechanisms used 
to allosterically regulate proteins.  One potential target of Ca2+ is Ca2+/calmodulin 
dependent protein kinase type II (CaMK-II).  CaMK-II is a multi-functional protein kinase 
known to influence cellular pathways such as cell motility and cell cycle progression.  
Within the cell cycle, CaMK-II promotes the expression of the regulator protein cyclin D1, 
which is necessary for cell cycle progression.  To further understand CaMK-II’s role in 
cyclin D1 expression, the binding partners of cytosolic CaMK-II were studied using mass 
spectrometry.  Several proteins were identified including β actin, β tubulins, tropomodulin- 
v 
3 and Flightless-I.  Flightless-I was of the most interest because of its role as a 
transcriptional co-activator of β-catenin-dependent genes such as cyclin D1 and its ability 
to translocate out of the nucleus following serum stimulation or CaMK-II activation.   
 For this study, I sought to determine whether the interaction between CaMK-II and 
Flightless-I mediates transcription of cyclin D1.  First, Flightless-I was linked to green 
fluorescent protein (GFP) and live cell imaging was performed.  Under serum stimulation 
or constitutive CaMK-II expression, GFP-Flightless-I was cytosolic.  Serum starvation or 
inhibition of CaMK-II expression resulted in the localization of GFP-Flightless-I to the 
nucleus.  Next, a luciferase based reporter gene assay was used to evaluate the effect of 
Flightless-I and CaMK-II on β-catenin-dependent transcription of cyclin D1.  Over-
expression of Flightless-I or inhibition of CaMK-II both resulted in decreased β-catenin-
dependent transcription; whereas suppression of Flightless-I by siRNA enhanced 
transcription.  Taken together, these results suggest a novel mechanism whereby the 
interaction between CaMK-II and Flightless-I influences gene transcription necessary for 
cell cycle progression. 
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Introduction 
Ca2+/Calmodulin Dependent Protein Kinase Type II 
 Ca2+/Calmodulin dependent protein kinase type II (CaMK-II) is a ubiquitously 
expressed multi-functional serine/threonine protein kinase.  CaMK-II is expressed in a 
variety of cell types and is encoded by four genes (α, β, δ and γ), which give rise to over 
three dozen CaMK-II subtypes through alternative splicing (Tombes et al., 2003).  Due to 
CaMK-II’s ubiquitous nature, it has been shown to influence numerous signaling 
pathways.  These pathways include neuron morphology and signaling, cell migration and 
cell cycle progression. 
 All four of the CaMK-II genes have a similar structure consisting of an amino-
terminal catalytic and regulatory domain, a central variable domain and a carboxy-terminal 
association domain (Figure 1).  The amino-terminus consists of 315-amino acids and 
contains ATP- and calmodulin-binding sites (Schulman et al., 1992).  The next 30-100 
amino acids comprise the variable domain where alternative splicing occurs leading to the 
multiple splice variants of CaMK-II (Tombes et al., 2003).  Finally, the carboxy-terminal 
association domain allows for the twelve monomers of CaMK-II to oligomerize and form a 
dodecameric protein (Kolb et al., 1998; Lantsman and Tombes, 2005). 
 CaMK-II is unique from other members of the calmodulin-dependent kinases 
because of its ability to become independent of Ca2+/CaM after initial activation.  Before 
the binding of Ca2+/CaM, CaMK-II is in an inactive state with the regulatory domain of the 
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 enzyme folded over the catalytic domain causing autoinhibition (Hudmon and Schulman, 
2002).  When Ca2+/CaM bind to CaMK-II the autoinhibitory arm is lifted, exposing the 
catalytic domain and allowing phosphorylation of the regulatory residue Thr287 to occur.  
Following phosphorylation of Thr287, the enzyme becomes independent of Ca2+/CaM and 
is able to phosphorylate target proteins.  These phosphorylated proteins have been shown 
to regulate multiple cellular functions including, but not limited to, synaptic plasticity, 
synaptic vesicle mobilization, modulation of ion channels, smooth muscle contraction and 
gene regulation (Gaertner et al., 2004).   
 
CaMK-II Function  
 CaMK-II is predominantly known for its role in regulating neuronal processes 
within the brain.  These processes include regulating long term potentiation and synaptic 
plasticity; both are required in memory and learning.  CaMK-II regulates these pathways 
through direct binding and/or phosphorylation of neuronal receptors and synaptic targets 
(Benfenati et al., 1992; Chen et al., 2001; Giese et al., 1998; He et al., 2000; Ito et al., 
1991; Yoshimura et al., 2002).  CaMK-II’s roles in neuronal processes appear to be 
mediated by the interaction of CaMK-II with components of the actin cytoskeleton (Caran 
et al., 2001; Fink et al., 2003; Shen and Meyer, 1999; Shen et al., 1998) 
 The actin cytoskeleton is vital for maintaining cell morphology and signal 
transduction pathways necessary for cell motility.  CaMK-II co-localizes with the actin 
cytoskeleton and influences cytoskeleton and focal adhesion dynamics.  Focal adhesions 
are critical signaling and structural hubs found in migratory cells and are formed through 
3 
adaptor protein interactions (Huttenlocher et al., 1995; Lauffenburger and Horwitz, 1996; 
Ridley et al., 2003).  Focal adhesion kinase (FAK) and paxillin are two such adaptor 
proteins essential for focal adhesion dynamics.  CaMK-II activation has been shown to 
promote dephosphorylation of FAK and paxillin and results in focal adhesion 
destabilization and cell migration (Easley et al., 2008) 
 CaMK-II is also involved in cell cycle progression.  Previous research has shown 
that upon CaMK-II inhibition, DNA synthesis is disrupted and cyclin D1 levels are 
decreased.  Cyclin D1 is a cell cycle regulatory protein which activates the cyclin-
dependent kinase, cdk4/6, to promote cell cycle progression out of the G1 phase of the cell 
cycle and into the S phase.  When cyclin D1 levels are decreased through the inhibition of 
CaMK-II, the cell arrests in the G1 phase of the cell cycle (Morris et al., 1998).  
Furthermore, the signaling molecules p44MAP kinase (ERK1) and p42MAP kinase (ERK2) which 
also control G1 phase cell cycle progression, were unaffected.  These results suggest that 
CaMK-II influences cyclin D1 levels to enable cell cycle progression; however the 
mechanism by which CaMK-II affects cyclin D1 has yet to be identified. 
 
CaMK-II Binding Partners 
 CaMK-II mediates regulation within cellular pathways through phosphorylation 
and protein binding.  Known binding proteins of CaMK-II include actin and tubulin 
(Easley et al., 2006; Shen et al., 1998), in addition to the newly discovered binding 
proteins tropomodulin-3, FLAP1, FLAP2 and Flightless-I (Seward et al., 2008).  Each of 
these proteins functions correspond to some of the known regulator pathways of CaMK-II. 
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 Actin 
 An actin localization domain within the variable region of CaMK-II is responsible 
for the association of certain CaMK-II’s with stress fibers of the actin cytoskeleton 
(O’Leary et al., 2006).  Upon actin binding, some CaMK-II isoforms have been shown to 
enhance dendritic arborization and synapse formation during brain development (Fink et 
al., 2003), while other isoforms act through the cytoskeleton to stabilize axons (Easley et 
al., 2006).  It is believed that the association of CaMK-II with actin may provide more 
efficient substrate phosphorylation of the neuronal substrates of CaMK-II including 
AMPA receptors, NMDA receptors and MAP2 (Shen et al., 1998). 
  
 Tubulin 
 Tubulin is the main protein of microtubule filaments known to associate with the 
actin cytoskeleton and influence cellular processes involved in maintaining cell 
morphology as well as cell motility.  The CaMK-II substrate, MAP-2, forms a bridge 
between tubulin and actin.  Upon MAP-2 phosphorylation by CaMK-II, the interaction 
between tubulin and actin is severed.  This loss of interaction has been suggested to cause 
dendritic morphogenesis critical to the formation of functional neuronal networks (Shen et 
al., 1998; Vallano and DeLorenzo, 1986; Vallano et al., 1986). 
 
 Tropomodulin-3 
 Tropomodulin-3 was recently discovered as a binding partner of CaMK-II  
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(Seward et al., 2008), however the interaction between Tropomodulin-3 and CaMK-II has 
not been further characterized.  Tropomodulin-3 was identified to bind actin filaments and 
actin monomers, in addition to negatively regulating cell migration.  Recent analysis 
revealed that, unlike previously characterized tropomodulins, tropomodulin-3 sequesters 
actin monomers with an affinity similar to its affinity for capping pointed ends of actin 
filaments (Fischer et al., 2006).  These results show that the affects tropomodulin-3 has on 
actin dynamic regulation are different from the other members of the tropomodulin family, 
which only cap actin filaments (Fowler et al., 2003; Fujisawa et al., 2001; Krieger et al., 
2001).  The interaction of tropomodulin-3 with CaMK-II may promote this difference in 
function, while regulating actin dynamics important in cell motility.  
  
 Flightless-I 
 Flightless-I and the Flightless-I leucine rich repeat associated proteins 1 and 2 
(FLAP1, FLAP2), are unique CaMK-II interacting proteins within the list of recently 
identified binding partners (Seward et al., 2008).  Flightless-I is a gelsolin related actin 
binding protein (GRABP) that was originally identified in D. melanogaster mutants that 
had lost the ability to fly.  The structure of Flightless-I consists of an amino-terminal 
leucine rich repeat domain, known to be important in protein-protein interactions, and a 
carboxy-terminal gelsolin-like domain which functions in actin binding and capping.  
Previous research has shown that Flightless-I, coupled with both association proteins, may 
be involved in cell migration as well as gene transcription (Archer et al., 2004; Cowin et 
al., 2007).  With respect to cell motility, wild type Flightless-I enhances wound healing in 
6 
mice whereas overexpression of Flightless-I impairs the healing process (Cowin et al., 
2007).  Flightless-I has been shown to function as both a promoter and repressor of gene 
transcription. Flightless-I was shown to promote transcriptional co-activation of estrogen 
and thyroid receptors (Lee et al., 2004).  However, Flightless-I also has been shown to 
inhibit the transcription of β-catenin-dependent promoters (Lee and Stallcup, 2006).  There 
has been speculation that Flightless-I may serve as the link between signal transduction 
pathways and regulation of the cytoskeleton.  However, the manner by which Flightless-I 
is able to translocate from the nucleus to the cytosol or how Flightless-I can both promote 
and inhibit transcription is not completely understood.  The interaction between CaMK-II 
and Flightless-I may serve as the means for regulating Flightless-I function. 
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Rationale 
 
 Current CaMK-II research predominately focuses on CaMK-II’s involvement in 
neuronal processes, specifically during development.  However, CaM-II is known to be 
involved in multiple non-neuronal pathways. Of particular interest was CaMK-II’s 
function in gene transcription necessary for cell cycle progression.  Previous research has 
shown that inhibition of CaMK-II decreases cellular cyclin D1 levels, resulting in G1 
phase cell cycle arrest (Morris et al., 1998).  The study showed that this G1 phase cell 
cycle arrest was due to CaMK-II’s effect on cyclin D1 and not through another G1 phase 
regulatory protein.  The CaMK-II isoforms within the NIH/3T3 cells used in this study do 
not contain nuclear localization domains, thus the transcription of cyclin D1 could not be 
inhibited through direct CaMK-II contact within the nucleus.  Lastly, known 
transcriptional regulators of cyclin D1 were evaluated to determine if these proteins were 
regulated through phosphorylation by CaMK-II, yet they are not.   
 To further these studies in hopes of discovering how CaMK-II regulates cyclin D1 
levels, the binding proteins of CaMK-II were identified.  Upon preliminary review of the 
proteins known functions, Flightless-I seemed to possess the most potential due to the 
presence of a nuclear localization domain as well as an ability to promote β-catenin-
dependent transcription, such as cyclin D1.    
8 
 The interaction between CaMK-II and Flightless-I was initially described in 
previous research.  Immunoprecipation experiments using full length CaMK-II constructs 
in addition to truncated CaMK-II constructs found that full length CaMK-II is necessary 
for efficient Flightless-I binding (Seward et al., 2008).  Kinase assays showed that 
Flightless-I is not a substrate of CaMK-II (Seward et al., 2008).  Also, when performing 
immunoblots on cells transfected with wild-type versus constitutively active CaMK-II, 
researchers found that more Flightless-I bound constitutively active CaMK-II (Seward et 
al., 2008) suggesting an activity-dependent interaction.  Finally, immunolocalization 
experiments in NIH/3T3 cells showed cytosolic Flightless-I localization during serum 
stimulation and upon serum starvation or CaMK-II inhibition Flightless-I localized to the 
nucleus (Seward et al., 2008).  In this study we confirm Flightless-I localization using live 
cell imaging, as well as provide evidence that CaMK-II influences β-catenin-dependent 
transcription and thus cell cycle progression through an activity-dependent interaction with 
Flightless-I. 
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Materials and Methods 
 
NIH 3T3 Cell Culture 
The Swiss mouse fibroblast cell line, NIH/3T3, was maintained in DMEM 
(Gibco/Invitrogen, Carlsbad, CA)  with 10% FBS, L-Glutamine, Penicillin, and 
Streptomycin at 37ºC in a 5% C02 incubator in plastic tissue culture dishes (Nunc, 
Rochester, NY). Serum free experiments were in DMEM with 0% FBS, L-Glutamine, 
Penicillin, and Streptomycin. 
 
Cell Harvest 
NIH/3T3 cell extracts were prepared by either scraping cells or detaching cells with 0.25% 
trypsin-EDTA, rinsing with PBS followed by centrifugation at 2000 x g for 5 minutes and 
then resuspending the cellular pellets in homogenization buffer.   Homogenization buffer 
consisted of 20mM HEPES(pH7.4), 2.6mM EGTA, 20mM MgCl2, 80mM β-glycerol 
phosphate, 0.1μM okadaic acid, 0.01mg/ml chymostatin, leupeptin, aprotinin, pepstatin, 
and soybean trypsin inhibitor.  The cell samples were sonicated for two 5 second bursts on 
ice and centrifuged at 10,000 x g for 15 minutes at 4ºC. 
 
Drug Treatment 
KN-93, a reversible calmodulin antagonist specific for CaMK-II, was used at varying  
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concentrations and added directly to cell cultures.   
 
Vectors 
GFP was linked to the amino-terminus of human flightless-I cDNA (obtained from OPEN 
Biosystems, Birmingham ALA). The cyclin D1 promoter-luciferase vector encompasses 
the first ~1kb of the cyclin D1 promoter (Hilton et al., 2005). FLAG-tagged human β-
catenin was provided by Dr. Barry Gumbiner, Univ. Virginia. The Super 8X TOPflash 
vector was obtained from Addgene, Cambridge MA (Veeman et al., 2003). All vectors 
were analyzed by restriction digestion and DNA sequencing, and by activity assays or 
immunoblots for determining the appropriate protein expression.   
 
Transfection 
Approximately 100% confluent cells in 100mm tissue culture dishes were sub-cultured 
into six-well cell culture dishes at approximately 5x105 cells per well.  A total of 3μg of 
plasmid DNA was transfected into each well of a six-well dish, with pBS-KS+ used as a 
carrier when necessary.  Lipofectamine 2000 (Invitrogen) was diluted in Opti-MEM with 
3% FBS (Invitrogen, Carlsbad, CA) and the plasmid DNA was diluted in the cell culture 
medium described under cell culture.  Cell culture medium was added immediately before 
transfection reagents were added.  Cells were harvested 24-40 hours post-transfection. 
 
Immunoblot 
Cell lysate proteins were separated on 4-15% or 10% SDS-PAGE gels using the Mini- 
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Protean II gel electrophoresis system (Bio-Rad, Hercules CA).  Proteins were transferred 
to 0.45μm nitrocellulose sheets for 1 hour at 100V and blocked with Tris Buffered Saline, 
0.01% Tween, and Sodium Azide (TBSTA), containing 5% BSA and 2% pre-immune 
serum of the secondary antibody host for 30 minutes.  Blots were then incubated for 
approximately 18hrs with primary antibodies at 1 μg/ml in 5% BSA/TBSTA.  Blots were 
washed three times with TBSTA and incubated for 2 hours with alkaline phosphatase-
conjugated secondary IgG at 2μg/ml in 5% BSA/TBSTA.  The blots were washed three 
times with TBSTA with a final wash in 0.1M NaCl and 5mM MgCl2 at pH 9.4 and 
developed with 0.25mg/mL of both nitro blue tetrazolium (NBT) and 5-bromo-4-chloro-3-
indolyl phosphate (BCIP). Blots were digitally scanned and densitometry was performed 
using the Image J program (National Institutes of Health).  
 
Imaging 
Phase contrast and fluorescent images were taken on an Olympus IX-70 inverted 
microscope using a 12-bit camera (Olympus, Melville, NY). Fluorescent images were 
taken with two second exposures using a 595 nm dichroic long pass filter (Chroma, 
Rockingham, VT) illuminated by a mercury arc lamp. The images were processed using 
Olympus Microsuite, v.5. 
 
Antibodies 
The mouse anti-flightless-I antibody was a purified monoclonal, mouse IgG, at 1μg/mL 
(Covance, Berkeley, CA).  Rabbit anti-GFP was purchased from Santa Cruz 
12 
Biotechnology, Santa Cruz CA.  The goat anti-mouse antibody was purchased from 
Jackson Immunological Laboratories, West Grove, PA. 
 
Luciferase assays 
After 24-40hrs of transfection with a reporter vector and FLAG-β-catenin, cells were 
harvested (as described under cell harvest) and assayed in triplicate using the Enhanced 
Luciferase Kit (BD Biosciences).  Luminescence readings were performed using a Wallac 
(Perkin Elmer) Victor2 Multilabel 96-well counter.  Luciferase values were normalized to 
total protein and are represented as fold-activation. 
 
siRNA 
siRNAs (up to 100 pico moles) were transfected with a total of 3.0 g pBluescriptKS+ or 
other DNA vectors into 5x105 NIH/3T3 cells using Lipofectamine 2000 as described under 
transfection. The flightless-I siRNA (Invitrogen) is listed 5’ to 3’.   
CCGCCGAGUGGUACAACAUUGACUU and 
AAGUCAAUGUUGUACCACUCGGCGG. 
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Results 
 
Constructing GFP-Flightless-I 
 To monitor the localization of Flightless-I in live cells, we constructed GFP-linked 
Flightless-I.  A human Flightless-I clone was obtained from OPEN Biosystems, PCR-
amplified and directionally inserted into the multiple cloning region of the mEGFP-C1 
vector (BD Biosciences Clontech). The restriction enzymes SalI and BamHI were used to 
cut both the insert and the vector.  Multiple tests were performed to confirm the ligation of 
Flightless-I into the mEGFP-C1 vector including a restriction enzyme digest, gene 
sequencing and Western blot. 
 First, a restriction enzyme digest was performed using the enzymes BamHI and 
SalI to remove the Flightless-I clone from the mEGFP-C1 vector.  The Flightless-I clone is 
approximately 3.8kB in length, whereas the mEGFP-C1 vector is 4.7kB.  DNA gel 
electrophoresis confirmed that the Flightless-I insert and mEGFP-C1 vector were present 
after the enzymatic digest as both a 3.8kB and 4.7kB band were observed on the gel 
(Figure 2A).   Next, sequencing of the GFP-Flightless-I plasmid was performed to ensure 
the entire Flightless-I gene was successfully ligated into the vector without mutations and 
in the correct reading frame.  Seven primers spanning the Flightless-I insert and regions 
within the GFP site of the vector were used.  Each of the primers provided approximately 
800bp of sequence and by aligning adjacent primer sequences the entire Flightless-I gene 
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was verified (Figure 2B).  No mutations were found and the gene appeared in the correct 
reading frame.  Finally, a Western blot was performed using NIH/3T3 cells overexpressing 
GFP-Flightless-I.  The plasmid encoding GFP-Flightless-I was transfected into NIH/3T3 
cells for 24 hours and the cell lysates were probed for Flightless-I using Western Blot 
analysis.  Flightless-I migrates at approximately 145kDa and GFP-Flightless-I at 
approximately 170kDa.  Western blotting indicates that both endogenous Flightless-I as 
well as GFP-Flightless-I were present as both a 145kDa and 170kDa band were detected 
(Figure 2C).  These tests confirm that the Flightless-I gene was successfully ligated into 
the mEGFP-C1 vector. 
 
Localization of GFP-Flightless-I in NIH/3T3 Cells 
 To determine if GFP-Flightless-I localizes in live cells as it does in fixed cells, 
GFP-Flightless-I was transfected into NIH/3T3 cells.  In fixed cells, Flightless-I gradually 
localized to the cytosol under cell proliferating conditions and to the nucleus under growth 
inhibited conditions or during CaMK-II inhibition (Seward et al., 2008).  Live cell imaging 
verified that cells overexpressing GFP-Flightless-I exhibit the same Flightless-I 
localization as cells expressing endogenous Flightless-I.  Under growth stimulated 
conditions, GFP-Flightless-I localized to the cell cytosol (Figure 3A) and upon serum 
starvation GFP-Flightless-I gradually translocated to the nucleus (Figure 3B).  The 
percentage of nuclear GFP-Flightless-I was averaged from at least ten cells per condition 
and ten regions of interest per cell to determine GFP-Flightless-I localization (Figure 3D).  
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These results are consistent with prior Flightless-I localization experiments and verify that 
GFP-linked Flightless-I retains intracellular Flightless-I location.   
 
CaMK-II Activity Dependent Localization of GFP-Flightless-I 
 Previous research suggests that Flightless-I localization is dependent on CaMK-II 
activation (Seward et al., 2008).  In order to further examine whether the activity state of 
CaMK-II drives Flightless-I localization, T287D CaMK-II and GFP-Flightless-I were co-
transfected into NIH/3T3 cells.  T287D CaMK-II is a constitutively active CaMK-II mutant 
with an Asp287 point mutant at Thr287, the autophosphorylation site, which renders CaMK-
II calcium independent.  Twenty four hours post-transfection, serum-free medium was 
added to the cells.  GFP-Flightless-I was imaged after 18 hours under serum-free 
conditions using epifluorescent microscopy.  In cells expressing T287D CaMK-II, GFP-
Flightless-I remained in the cytosol under serum starvation (Figure 3C).  Localization was 
calculated by averaging total nuclear fluorescence from ten cells and within ten regions of 
interest per cell (Figure 3D).  These results support prior localization experiments and 
confirm that CaMK-II activation directs Flightless-I localization. 
 
β-Catenin Dependent Transcription 
 The second part of this study investigated the role of CaMK-II and Flightless-I on 
transcriptional regulation. To do this, the Super 8xTOPflash-luc (TOPflash) and cyclinD1-
luc reporter vectors were obtained.  TOPflash and cyclinD-luc are luciferase reporters of β-
catenin-mediated transcriptional activation.  Each vector contains a Tcf/Lef promoter 
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region upstream from the luciferase gene that allows for β-catenin binding.  Upon binding, 
luciferase is expressed.  The TOPflash vector contains eight Tcf/Lef binding sites; whereas 
cyclinD1-luc contains only one in addition to the first one thousand nucleotides of the 
cyclin D1 promoter.   
 Because the TOPflash reporter vector contains eight Tcf/Lef binding sites and 
cyclinD1-luc contains only one, an initial luciferase assay was performed to determine if 
the number of Tcf/Lef binding sites affects luciferase expression.  NIH/3T3 cells were co-
transfected with either cyclinD1-luc or TOPflash and FLAG-β-catenin.  Forty hours post-
transfection cells were harvested and luciferase-luminescence was measured using a 
luminometer.  CyclinD1-luc has an approximate 2-fold activation in the presence of β-
catenin; whereas TOPflash has an approximate 70-fold luciferase activation, due to the 
eight Tcf/lef binding sites of TOPflash (Figure 4A).  These results confirm that both 
reporter vectors are β-catenin-dependent, with the TOPflash vector having significantly 
enhanced luciferase activation as compared to the cyclinD1-luc vector.  
 
Flightless-I inhibits β-catenin-dependent Transcription 
 Flightless-I has been shown to inhibit Tcf/Lef transcription under serum starvation 
conditions (Lee and Stallcup, 2006).  To determine whether Flightless-I overexpression 
impairs β-catenin-dependent transcription, Flightless-I was co-transfected into NIH/3T3 
cells with either TOPflash or cyclinD1-luc and FLAG-β-catenin.  Forty hours post-
transfection a luciferase assay was performed.  Increased Flightless-I significantly reduced 
luciferase-luminescence in the presence of either the cyclinD1-luc reporter (Figure 4B) or 
17 
the TOPflash reporter (Figure 4C).  Furthermore, Flightless-I’s effect on luciferase-
luminescence was dose-dependent.  Transfecting higher concentrations of Flightless-I 
further impaired β-catenin-dependent transcription (Figure 4B+C).   
 To investigate how Flightless-I regulates β-catenin-mediated transcription, we first 
evaluated whether Flightless-I promotes β-catenin-dependent degradation.  A non-
degradable S45A β-catenin plasmid was constructed by mutating Ser45 to Ala45, the 
ubiquitination phosphophorylation site of glycogen synthase kinase-3 (GSK-3).  Non-
degradable S45A β-catenin was co-transfected into NIH/3T3 cells with the TOPflash 
reporter vector and increasing concentrations of Flightless-I.  Although total luciferase-
luminescence increased in the presence of S45A β-catenin, increasing concentrations of 
Flightless-I continued to have a dose-dependent inhibitory effect (Figure 4C).  This result 
indicates that Flightless-I inhibition of Tcf/Lef gene transcription is independent of β-
catenin degradation.   
 
Effect of CaMK-II on β-catenin-dependent Transcription 
 Because Flightless-I inhibited β-catenin-dependent transcription through means 
other than direct β-catenin degradation, we next evaluated whether inhibition of CaMK-II 
would have a similar effect on β-catenin-dependent transcription. To address this question, 
NIH/3T3 cells were co-transfected with either cyclinD1-luc or TOPflash in addition to 
either FLAG-β-catenin or S45A β-catenin.  Sixteen hours post-transfection, the CaMK-II 
inhibitor KN-93 was added for 24 hours.  Luciferase assays showed decreased 
luminescence in the presence of KN-93.  This inhibition occurred in a dose-dependent 
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manner using both cyclinD1-luc and TOPflash and either Flag-β-catenin or S45A β-catenin 
(Figure 5A+B).  Thus, like Flightless-I expression, inhibition of CaMK-II decreases β-
catenin-dependent transcription independent of β-catenin degradation. 
 In an attempt to enhance β-catenin-dependent transcription, we overexpressed 
either wild-type CaMK-II or T287D CaMK-II.  Forty hours post-transfection, luciferase-
luminescence was measured in each sample.  The results show that whether in the presence 
of the cyclinD1-luc or TOPflash reporter vector and FLAG-β-catenin, luciferase-
luminescence was inhibited during CaMK-II overexpression (Figure 6A+B).  Based on 
these results, CaMK-II may be activating other transcription regulator proteins such as 
transforming growth factor activated kinase 1 (TAK1) which has been shown to stimulate 
nemo-like kinase (NLK) activity and results in decreased β-catenin-dependent transcription  
(Ishitani et al., 1999). 
 
Flightless-I suppression promotes β-catenin Dependent Transcription 
 To confirm overexpression of Flightless-I caused inhibition of β-catenin-dependent 
transcription, Flightless-I suppression experiments were performed using small interfering 
RNA (siRNA).  Flightless-I siRNA interferes with the expression of Flightless-I and 
results in a decrease of Flightless-I gene expression.  NIH/3T3 cells were co-transfected for 
40 hours with the CyclinD1-luc reporter vector and increasing concentrations of Flightless-
I siRNA.  Western immunoblot analysis of the cell lysates confirmed the inhibition of 
Flightless-I expression (Figure 7A) and a luciferase assay showed an increase in luciferase-
luminescence upon increased concentrations of Flightless-I siRNA (Figure 7B).     
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 To further substantiate this evidence and show that the effect siRNA Flightless-I 
was having on β-catenin-dependent transcription was a direct result of Flightless-I 
suppression, increasing amounts of GFP-Flightless-I were co-transfected into cells with 
siRNA.  GFP-Flightless-I reversed the effects of siRNA Flightless-I, and once again β-
catenin-dependent transcription was inhibited (Figure 7B). 
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Discussion 
 
 This study provides the first direct evidence linking CaMK-II and β-catenin-
dependent transcription.  Previous studies have shown that CaMK-II inhibition within 
NIH/3T3 cells promotes a decrease in cyclin D1 (Morris et al., 1998), a β-catenin-
dependent gene.  However, all CaMK-II variants in NIH/3T3 cells are strictly cytosolic, 
and the transcription factors necessary for cyclin D1 expression are not substrates of 
CaMK-II (Morris et al., 1998).  Flightless-I, a known binding partner of CaMK-II, has 
previously been shown to be involved in cell motility and β-catenin dependent gene 
regulation (Archer et al., 2004; Cowin et al., 2007; Lee and Stallcup, 2006), which are two 
known CaMK-II functions (Easley et al., 2008; Morris et al., 1998).  Our results, here, 
suggest a novel means by which CaMK-II influences β-catenin-dependent transcription by 
sequestering Flightless-I to the cytosol (Figure 8) 
 While CaMK-II activity appears to influence Flightless-I localization to the cytosol 
and thus promote β-catenin-dependent transcription, expression of T287D CaMK-II actually 
inhibited β-catenin-dependent transcription.  This result seems contradictory to the data 
presented here, but in fact, this finding can be explained because CaMK-II is involved in 
other pathways that could impair β-catenin-dependent transcription.  Previous research has 
shown that T287D CaMK-II promotes the loss of cell attachment due to rapid focal 
adhesions turn over, resulting in cell rounding which ultimately leads to cell death (Easley 
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et al., 2008).  Also, not all of the phosphosphorylation substrates of CaMK-II have been 
identified so it is possible that CaMK-II may directly or indirectly promote the 
phosphorylation of proteins involved in β-catenin degradation such as GSK3-β or E3 
ligase, resulting in decreased β-catenin-dependent transcription.  Another possible 
explanation for a decrease in β-catenin-dependent transcription during overexpression of 
CaMK-II is that CaMK-II may be inhibiting β-catenin degradation resulting in an 
accumulation of β-catenin within the cytosol.  Excess β-catenin has been shown to promote 
p53 activation which leads to repressed cyclin D1 transcription (Damalas et al., 1999; 
Rocha et al., 2003).  Finally, CaMK-II may inhibit β-catenin-dependent transcription 
through the phosphorylation of Tak1 or NLK.  These proteins have both been shown to 
down regulate transcriptional activation of β-catenin-dependent genes (Ishitani et al., 
1999).  Thus, expression of T287D CaMK-II is unable to promote β-catenin-dependent 
transcription due to the activation of other pathways which result in the inhibition of β-
catenin-dependent transcription.  
 The canonical and non-canonical Wnt pathways are two separate pathways that 
may cross-talk due to the interaction between Flightless-I and CaMK-II.  Activation of the 
canonical Wnt pathway has been shown to promote β-catenin-dependent transcription, 
while activation of the non-canonical Wnt pathway has been shown to regulate cell 
motility (Kohn and Moon, 2005; Moon, 2005) .  Previous research has shown that the non-
canonical Wnt pathway inhibits β-catenin-dependent transcription by promoting β-catenin 
degradation (Topol et al., 2003).  Here we show that the activation of CaMK-II through the 
non-canonical Wnt pathway promotes β-catenin-dependent transcription by sequestering 
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Flightless-I to the cytosol (Figure 8).  Thus, this research suggests a novel means for cross-
talk to occur between the canonical and non-canonical Wnt pathways (Figure 9).  
   Recently, the differential expression of CaMK-II genes involved in zebrafish, 
Danio rerio, development were characterized and include camk2a1,camk2b1, camk2g1, 
camk2g2, camk2d1, camk2d2.  Each gene was shown to be temporally expressed within 
many tissues; including the heart, brain, retina, gut, pectoral fins, and epidermal tissue 
during the first three days of development (Rothschild et al., 2007).  My current research 
primarily focused on the interaction of one CaMK-II gene, δ CaMK-II, and Flightless-I.  
Both variants of the δ CaMK-II gene in zebrafish (camk2d1 and camk2d2) were shown to 
have low expression throughout the first three days of development in the hindbrain, 
forebrain, epidermal tissue and retinal epithelium (Rothschild et al., 2007).  By mapping 
the expression of Flightless-I during early zebrafish development, we would hope to find 
similar Flightless-I localization patterns.  The next step would be to analyze any effect the 
interactions between the two proteins are having on cyclin D1 levels, in a tissue specific 
manner throughout different stages of development.  Using morpholino antisense 
oligonucleotides (MO) directed against the zebrafish δ CaMK-II genes, camk2d1 and 
camk2d2, the expression of δ CaMK-II would be inhibited.  After designing cyclin D1 
primers, RT-PCR could be performed on zebrafish containing the camk2d1 and camk2d2 
morpholinos to determine any changes in the levels of cyclin D1.   This research could be 
furthered by not only assaying this interaction in δ CaMK-II zebrafish genes, but rather all 
of the known zebrafish CaMK-II genes. 
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Figure 1. CaMK-II Structure. CaMK-II contains an amino-terminal catalytic domain, 
a central regulatory domain containing an inhibitory site as well as a Ca2+/CaM binding 
site and a carboxy-terminal variable domain. 
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Figure 2. Constructing GFP-Flightless-I.  GFP was ligated to the N-terminal side of 
human Flightless-I cDNA. A. DNA electrophoresis of a GFP-flightless-I restriction 
enzyme digest shows uncut GFP-Flightless-I in lane two, Sal-I linearized GFP-
Flightless-I in lane three and Sal-I/BamHI double digested GFP-Flightless-I in lane 
four. B. A schematic of GFP-linked Flightless-I and the primers used to obtain 
sequence. C. 20μg of lysate from un-transfected (left lane) and GFP-Fli-I transfected 
cells (right lane) were hybridized with anti-Fli-I.  Fli-I migrates at ~145kDa and GFP-
Fli-I at ~170kDa.   
            1        2  3     4 
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Figure 3.  Flightless-I is retained in the cytosol by CaMK-II.  GFP-Flightless-I was 
transfected alone (A,B) or with T287D CaMK-II (C) and then either maintained in A: 
complete medium or B,C: serum starved for 18 hours.  Live conventional epifluorescent 
microscopy was used to image cells.  Scale bar = 10μm. D: The percentage of total 
fluorescence that is nuclear was averaged from at least ten cells per condition and ten 
regions of interest per cell. 
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Figure 4.  Flightless-I suppresses β-catenin-dependent transcription.  Luciferase assays 
were performed 40 hours post-transfection of NIH/3T3 cells in complete medium. Fold-
activation of luciferase was measured.  A: Cells were co-transfected with 1μg FLAG-β-catenin 
and either 1μg CyclinD1-luc or 0.5μg TOPflash-luc. B:  Indicated amounts (μg) of GFP-Fli-I 
were co-transfected with 1μg FLAG-β-catenin and 1μg CyclinD1-luc. C: Indicated amounts 
(μg) of GFP-Fli-I were co-transfected with 0.5μg TOPflash-luc and either 1μg of FLAG-β-
catenin or 1μg of S45A FLAG-β-catenin. 
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Figure 5. Inhibition of CaMK-II suppresses β-catenin-dependent transcription. 
Luciferase assays were performed 40 hours post-transfection of NIH/3T3 cells in 
complete medium. Fold-activation of luciferase was measured. Cells were co-
transfected with either 1μg FLAG-β-catenin or 1μg of S45A FLAG-β-catenin in the 
presence of A: 1μg CyclinD1-luc or B: 0.5μg of TOPflash-luc. KN-93 was added in the 
amounts indicated (μM). 
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Figure 6. Over-expression of CaMK-II inhibits β-catenin-dependent transcription. 
Luciferase assays were performed 40 hours post-transfection of NIH/3T3 cells in 
complete medium. Fold-activation of luciferase was measured. Cells were co-
transfected with 1μg FLAG-β-catenin in the presence of A: 1μg CyclinD1-luc or B: 
0.5μg of TOPflash-luc. Wild-type δ CaMK-II or T287D CaMK-II were added in the 
amounts indicated (μg). 
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Figure 7.  siRNA suppression of Flightless-I enhances cyclin D1 transcription. 
Luciferase assays were performed 40 hours post-transfection of NIH/3T3 cells in 
complete medium. Luciferase values are represented as fold-activation relative to cells 
transfected with cyclinD1-luc alone. A: Anti-Fli-I immunoblot of the relative levels of 
endogenous and transfected Fli-I corresponding to transfected cells used in lanes 1-10 of 
part B. B: Cells were co-transfected with 1.0μg of cyclinD1-luc and indicated amounts 
(pico moles) of either control or Flightless-I siRNA (lanes 1-6).  Lanes 7-8 show cells 
co-transfected with 1.0μg of cyclinD1-luc and indicated amounts (μg) of GFP-Fli.  
Lanes 9-10 show cells co-transfected with 1.0μg of cyclinD1-luc and indicated amounts 
(μg) of GFP-Fli in the presence of 10picomoles of Flightless-I siRNA.  
  1          2          3          4          5          6           7            8         9         10 
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Figure 8. Model of CaMK-II and Flightless-I’s Interaction.  When intracellular Ca2+ 
levels rise, CaM binds Ca2+.  Ca2+/CaM binds CaMK-II, activating the kinase.  In its 
activated state, CaMK-II is capable of binding Flightless-I, which is otherwise 
sequestered to the nucleus.  Within the nucleus Flightless-I inhibits Tcf/Lef dependent 
gene transcription.   
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Figure 9. Model of CaMK-II’s Role in Canonical and Non-canonical Wnt 
Pathways.  Upon activation of the non-canonical Wnt pathway, intracellular Ca2+ levels 
rise and CaMK-II becomes activated.  Activated CaMK-II sequesters Flightless-I to the 
cytosol thus promoting Tcf/Lef dependent gene transcription, the nuclear target of the 
canonical Wnt pathway. 
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